Mori Cortex extract ameliorates nonalcoholic fatty liver disease( NAFLD) and insulin resistance in high-fat-diet/streptozotocininduced type 2 diabetes in rats  

作　　者：MA Li-Li YUAN Yan-Yan ZHAO Ming ZHOU Xin-Rong Tashina Jehangir WANG Fu-Yan XI Yang BU Shi-Zhong 

机构地区：[1]Runliang Diabetes Laboratory, Diabetes Research Center, School of Medicine, Ningbo University

出　　处：《Chinese Journal of Natural Medicines》2018年第6期411-417,共7页中国天然药物（英文版）

基　　金：supported by Ningbo Science and Technology Innovation Team Program(No.2014B82002);the National Natural Science Foundation of China(Nos.81370165,81501421,and 31301068);the Natural Science Foundation of Ningbo(Nos.2013A610209 and 2015A610217);Fang Runhua Fund of Hong Kong and K.C.Wong Magna Fund of Ningbo University

摘　　要：Nonalcoholic fatty liver disease(NAFLD) and type 2 Diabetes Mellitus(T2 DM) are highly prevalent diseases and are closely associated, with NAFLD being present in the majority of T2 DM patients. In Asian traditional medicine, Mori Cortex is widely used for the treatment of diabetes and hyperlipidemia. However, whether it has a therapeutic effect on T2 DM associated with NAFLD is still unknown. The present study showed that the oral treatment with Mori Cortex extract(MCE; 10 g·kg-1·d-1) lowered the blood lipid levels and reversed insulin resistance(IR) in high fat-diet/streptozotocin-induced type 2 diabetes in rats. The expression levels of sterol receptor element-binding protein-1 c(SREBP-1 c) and carbohydrate-responsive element binding protein(Ch REBP), which are involved in steatosis in NAFLD rats, were measured in the liver samples. MCE decreased the protein and m RNA expression levels of SREBP-1 c and Ch REBP. In conclusion, down-regulation of SREBP-1 c and Ch REBP might contribute to the protective effect of MCE on hepatic injury and IR in the rats with T2 DM associated with NAFLD.Nonalcoholic fatty liver disease（NAFLD） and type 2 Diabetes Mellitus（T2 DM） are highly prevalent diseases and are closely associated, with NAFLD being present in the majority of T2 DM patients. In Asian traditional medicine, Mori Cortex is widely used for the treatment of diabetes and hyperlipidemia. However, whether it has a therapeutic effect on T2 DM associated with NAFLD is still unknown. The present study showed that the oral treatment with Mori Cortex extract（MCE; 10 g·kg-1·d-1） lowered the blood lipid levels and reversed insulin resistance（IR） in high fat-diet/streptozotocin-induced type 2 diabetes in rats. The expression levels of sterol receptor element-binding protein-1 c（SREBP-1 c） and carbohydrate-responsive element binding protein（Ch REBP）, which are involved in steatosis in NAFLD rats, were measured in the liver samples. MCE decreased the protein and m RNA expression levels of SREBP-1 c and Ch REBP. In conclusion, down-regulation of SREBP-1 c and Ch REBP might contribute to the protective effect of MCE on hepatic injury and IR in the rats with T2 DM associated with NAFLD.

关 键 词：Mori CORTEX EXTRACT Type 2 diabetes Non-alcoholic fatty liver STEROL receptor element-binding protein-It Carbohy-drate-responsive ELEMENT binding protein 

分 类 号：R965[医药卫生—药理学]